- Home
- VRCA vs CLPR Comparison
VRCA vs CLPR Comparison
Compare VRCA & CLPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | VRCA | CLPR |
|---|---|---|
| Founded | 2013 | 2015 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 87.5M | 59.1M |
| IPO Year | 2018 | 2015 |
Fundamental Metrics
Financial Performance| Metric | VRCA | CLPR |
|---|---|---|
| Price | $6.26 | $3.21 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $17.00 | N/A |
| AVG Volume (30 Days) | ★ 124.8K | 57.4K |
| Earning Date | 06-11-2026 | 06-05-2026 |
| Dividend Yield | N/A | ★ 11.88% |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $109,997,000.00 |
| Revenue This Year | $372.93 | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 5.82 |
| 52 Week Low | $0.39 | $3.04 |
| 52 Week High | $9.82 | $4.68 |
Technical Indicators
Market Signals| Indicator | VRCA | CLPR |
|---|---|---|
| Relative Strength Index (RSI) | 52.33 | 40.82 |
| Support Level | $5.22 | $3.04 |
| Resistance Level | $6.44 | $3.96 |
| Average True Range (ATR) | 0.41 | 0.12 |
| MACD | 0.12 | -0.00 |
| Stochastic Oscillator | 74.26 | 38.60 |
Price Performance
Historical ComparisonAbout VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.
About CLPR Clipper Realty Inc.
Clipper Realty Inc is a self-administered and self-managed real estate company. It acquires, owns, manages, operates, and repositions multifamily residential and commercial properties in the New York metropolitan area, with a portfolio in Manhattan and Brooklyn. It has classified its reporting segments into Residential Rental Properties and Commercial Rental Properties. The company derives its revenue mostly from the Residential segment.